An amino disaccharide that consists of N-acetyl-D-glucosamine having an N-acetyl-6-O-sulfo-beta-D-galactosaminyl residue attached at O-4.


IUPAC name: 4-((3-((4-aminobutyl)amino)propyl)amino)-4-oxobutanoic acid; SMID (https://www.smid-db.org/): maspid#6


FOSAPREPITANT DIMEGLUMINE

An organoammonium salt obtained by reaction of fosaprepitant with two equivalents of 1-deoxy-1-(methylamino)-D-glucitol. A substance P/neurokinin 1 (NK1) receptor antagonist. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting and postoperative nausea and vomiting


difluorobenzene

Any member of the class of fluorobenzenes containing a mono- or poly-substituted benzene ring carrying two fluorine atoms.


A difluorobenzene carrying fluoro groups at positions 1 and 3.


A difluorobenzene carrying fluoro groups at positions 1 and 2.


name: 3-methyl-2-[(4-methylphenyl)sulfonylamino]pentanoic acid (4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl) ester


An organic anionic group obtained by deprotonation of the carboxy groups of S-3-[(2R)-phycoerythrobilin]-L-cysteine residue; major species at pH 7.3.


HOMIDIUM BROMIDE

The organic bromide salt of ethidium.


uridylyl-L-threonine(1-) residue

An alpha-amino-acid residue anion obtained by deprotonation of the phosphate OH group of uridylyl-L-threonine residue; major species at pH 7.3.


A ceramide that is the N-palmitoyl (hexadecanoyl) derivative of 4-hydroxyeicosasphinganine.


Milling yellow 3G

An organic sodium salt that is the monosodium salt of 5-chloro-2-[5-hydroxy-3-methyl-4-({4-[(4-methylbenzene-1-sulfonyl)oxy]phenyl}diazenyl)-1H-pyrazol-1-yl]benzene-1-sulfonic acid.


hydroxamic acid

A compound, RkE(=O)lNHOH, derived from an oxoacid RkE(=O)l(OH) (l =/= 0) by replacing -OH with -NHOH, and derivatives thereof. Specific examples of hydroxamic acids are preferably named as N-hydroxy amides.


acetohydroxamic acids

Any hydroxamic acid in which the N-acyl group is specified as acetyl.


vorinostat

A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and  hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).


A  member of the class of acetohydroxamic acids that is trimethylenediamine bearing N-hydroxy and N-acetyl substituents.


methioninehydroxamic acid

A hydroxamic acid that is the amide of methionine hydroxylated at the amidic nitrogen.


glutamine hydroxamate

A hydroxamic acid that is L-glutamine hydroxylated at N-5.


A hydroxamic acid resulting from the formal condensation of the carboxy group of (Z)-11-methyldodec-2-enoic acid with the nitrogen of hydroxylamine.


BW B70C

A  hydroxamic acid that is urea in which both the hydrogens attached to one of the nitrogens are replaced by a hydroxy and a (1E)-1-[3-(4-fluorophenoxy)phenyl]but-1-en-3-yl group. A selective inhibitor of arachidonate 5-lipoxygenase, it can be used for the treatment of asthma.


SALICYLHYDROXAMIC ACID

A hydroxamic acid that is N-hydroxybenzamide carrying a phenolic hydroxy group at position 2.


serine hydroxamate

A hydroxamic acid obtained by formal condensation of the carboxy group of serine with the amino group of hydroxylamine.


ibuproxam

A hydroxamic acid obtained by formal condensation of the carboxy group of ibuprofen with the amino group of hydroxylamine. Used for treatment of pain and inflammation associated with musculoskeletal and joint disorders.


A hydroxamic acid that is biphenyl-4-amine bearing N-hydroxy and N-acetyl substituents.


fosmidomycin

Propylphosphonic acid in which one of the hydrogens at position 3 is substituted by a formyl(hydroxy)amino group. An antibiotic obtained from Streptomyces lavendulae, it specifically inhibits DXP reductoisomerase (EC 1.1.1.267), a key enzyme in the non-mevalonate pathway of isoprenoid biosynthesis.


A hydroxamic acid that is N-hydroxy-D-valinamide in which the alpha-amino group has been substituted by isopropoxy and [biphenyl]-4-ylsulfonyl groups. A selective matrix metalloproteinase-2 (MMP-2) inhibitor, it is one of the most potent inducers of autophagy. Its physiological roles include angiogenesis, cancer metastasis, embryogenesis, tissue remodeling in development, and wound healing.


belinostat

A hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.


glycine hydroxamate

A hydroxamic acid obtained by formal condensation of the carboxy group of glycine with the amino group of hydroxylamine.


marimastat

A secondary carboxamide resulting from the foraml condensation of the carboxy group of (2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the alpha-amino group of N,3-dimethyl-L-valinamide.


A dialkylresorcinol where the alkyl groups at positions 2 and 5 are hexyl and 7-oxoheptyl respectively.


A beta-D-glucosylceramide obtained by formal condensation of the carboxy group of icosanoic acid with the amino group of beta-D-glucosyl-(1<->1')-(4E,14Z)-sphingadienine.


L-SULFORAPHANE

A sulforaphane in which the sulfinyl group has S configuration.


A tripeptide composed of glycine, L-leucine and L-methioninamide joined in sequence by peptide linkages. It is a C-terminal fragment of substance P.


Ala-Gly-His

A tripeptide composed of L-alanine, glycine, and L-histidine joined in sequence by peptide linkages.


Glu-Asp-Arg

A tripeptide composed of L-glutamic acid, L-aspartic acid, and L-arginine joined in sequence by peptide linkages.


Ala-Leu-Ala

A tripeptide composed of L-alanine, L-leucine and L-alanine joined in sequence by peptide linkages.


norophthalmic acid

A tripeptide composed of L-glutamic acid, L-alanine, and glycine residues joined in sequence by peptide linkages.


Ac-D-Phe-His-D-Pro

A tripeptide comprising N(2)-acetyl-D-phenylalanine, L-histidine and D-proline residues coupled in sequence.


A branched tripeptide in which L-homocysteine and L-valine are linked via peptide bonds to the epsilon- and alpha-nitrogens respectively of L-lysine.


Gly-Pro-Hyp

A  tripeptide composed of glycine, L-proline and 3-hydroxy-L-proline units joined in sequence by peptide linkages.


Thr-Ala-His

A tripeptide composed of L-threonine, L-alanine, and L-histidine joined by peptide linkages.


Thr-Pro-Pro

A tripeptide composed of one L-threonine and two L-proline units joined by peptide linkages.


Phe-Ala-Pro

A tripeptide composed of L-phenylalanine, L-alanine and L-proline joined in sequence by peptide linkages.


Pro-Glu-Ile

A tripeptide composed of L-proline, L-glutamic acid and L-isoleucine joined in sequence by peptide linkages.


Leu-Leu-Ser

A tripeptide composed of two L-leucine units and L-serine joined in sequence by peptide linkages.


Phe-Arg-Thr

A tripeptide composed of L-phenylalanine, L-arginine, and L-threonine joined in sequence by peptide linkages.


Phe-Tyr-Asp

A tripeptide composed of L-phenylalanine, L-tyrosine and L-aspartic acid joined by peptide linkages.


Leu-Leu-Asp

A tripeptide composed of two L-leucine units joined to L-aspartic acid by a peptide linkage.


Trp-Ala-Gly

A tripeptide composed of L-tryptophan, L-alanine, and glycine joined by peptide linkages.


Leu-Ala-Gly

A tripeptide composed of L-leucine, L-alanine and glycine joined in sequence by peptide linkages.


Leu-Ala-Ser

A tripeptide composed of L-leucine, L-alanine and L-serine joined in sequence by peptide linkages.


Glu-Asp-Ile

A tripeptide composed of L-glutamic acid, L-aspartic acid and L-isoleucine joined in sequence by peptide linkages.


Leu-Gly-Gly

A tripeptide composed of one L-leucine and two glycine residues joined in sequence.


Gln-Phe-Tyr

A tripeptide composed of L-glutamine, L-phenylalanine and L-tyrosine joined in sequence by peptide linkages.


Glu-Ile-Ser

A tripeptide composed of L-glutamic acid, L-isoleucine and L-serine joined by peptide linkages.


L-lysyl-D-alanyl-D-alanine

A linear tripeptide comprised of one L-lysine residue and two D-alanyl residues.


Phe-Trp-Trp

A tripeptide composed of L-phenylalanine and two L-tryptophan units joined by peptide linkages.


Gln-Cys-Cys

A tripeptide composed of one L-glutamine and two L-cysteine units joined by peptide linkages.


Asp-Gln-Arg

A tripeptide composed of L-aspartic acid, L-glutamine and L-arginine joined in sequence by peptide linkages.


Glu-Glu-Gln

A tripeptide composed of two L-glutamic acid and one L-glutamine units joined by peptide linkages.


Leu-Leu-Ala

A tripeptide composed of two L-leucine units joined to L-alanine by a peptide linkage.


Thr-Asp-Gly

A tripeptide composed of L-threonine, L-aspartic acid, and glycine joined by a peptide linkage.


Gly-Gly-Pro

A tripeptide composed of glycine, glycine and L-proline amino acids joined in sequence by peptide linkages.


Leu-Asp-Ser

A tripeptide composed of L-leucine, L-aspartic acid and L-serine joined in sequence by peptide linkages.


Glu-Val-Val

A tripeptide composed of L-glutamic acid and two L-valine units joined in sequence by peptide linkages.


Cys-Asp-Gly

A tripeptide composed of L-cysteine, L-aspartic acid and glycine joined in sequence by peptide linkages.


Ala-Gly-Pro

A tripeptide composed of L-alanine, glycine, and L-proline joined in sequence by peptide linkages.


Phe-Phe-Asp

A tripeptide composed of two L-phenylalanine units and L-aspartic acid joined by peptide linkages.


Ala-Asp-Gly

A tripeptide composed of L-alanine, L-aspartic acid, and glycine units joined in sequence by peptide linkages.


Leu-Leu-Tyr

A tripeptide composed of L-leucine, L-leucine and L-tyrosine joined in sequence by peptide linkages.


Ala-Ala-Ser

A tripeptide composed of two L-alanyl units and an L-serine joined by peptide linkages.


A tripeptide formed between L-Hcy, L-Lys and L-Leu in a linear sequence, with the peptide linkage between Hcy and Lys being from the carboxy group of the Hcy to the epsilon-nitrogen of the lysine.


A tripeptide comprising N(2)-acetyl-D-phenylalanine, L-histidine and D-prolinamide residues coupled in sequence.


Gly-Gly-Leu

A tripeptide composed of glycine, glycine and L-leucine residues joined in sequence.


Leu-Val-Asp

A tripeptide composed of L-leucine, L-valine and L-aspartic acid joined in sequence by peptide linkages.


A tripeptide comprising of L-arginine, 3-methyl-L-valine and L-arginine joined in sequence by peptide linkages and in which the amino terminus is substituted by a [4-(carbamimidamidomethyl)phenyl]acetyl group and the carboxy terminus is substituted by a (4-carbamimidoylbenzyl)amino group. It is a highly potent inhibitor of furin endoprotease (Ki = 5.5 pM) that has anti-infectious activity.


Ala-Gly-Ser

A tripeptide composed of L-alanine, glycine, L-serine joined in sequence by peptide linkages.


Leu-Ala-Asp

A tripeptide composed of L-leucine L-alanine, and L-aspartic acid joined in sequence by peptide linkages.


A tripeptide formed between L-Hcy, L-Lys and L-Ala in a linear sequence, with the peptide bond between Hcy and Lys being from the carboxy group of the Hcy to the epsilon-nitrogen of the lysine.


A cell permeable inhibitor for caspase proteases.


Ile-Leu-Pro

A tripeptide composed of L-isoleucine, L-lrucine, and L-proline joined in sequence by peptide linkages.


Glu-Cys-Cys

A tripeptide composed of one L-glutamic acid and two L-cysteine units joined by peptide linkages.


phaseolotoxin

A tripeptide resulting from the formal condensation of the carboxy group of N(5)-[amino(sulfoamino)phosphoryl]-L-ornithine with the N-terminal amino group of L-alanyl-L-arginine. A toxin produced by cultured Pseudomonas syringae, the causal agent of halo blight disease in bean plants.


Leu-Pro-Tyr

A tripeptide composed of L-leucine, L-proline and L-tyrosine joined in sequence by peptide linkages.


Leu-Thr-Ala

A tripeptide composed of L-leucine, L-threonine and L-alanine joined in sequence by peptide linkages.


Leu-Phe-Asn

A tripeptide composed of L-leucine, L-phenylalanine and L-asparagine joined in sequence by peptide linkages.


Glu-Ile-Val

A tripeptide composed of L-glutamic acid, L-isoleucine and L-valine joined in sequence by peptide linkages.


Lys-Ser-Trp

A tripeptide composed of L-lysine, L-serine and L-tryptophan joined in sequence by peptide linkages.


Lys-Asp-Tyr

A tripeptide composed of L-lysine, L-aspartic acid and L-tyrosine joined in sequence by peptide linkages.


Thr-Thr-Asp

A tripeptide composed of two L-threonine units and L-aspartic acid joined by peptide linkages.


Ala-Ala-Ala

A tripeptide composed of three L-alanine units joined by peptide linkages.


Phe-Trp-Ala

A tripeptide composed of L-phenylalanine, L-tryptophan, and L-alanine joined by peptide linkages.


Gly-Gly-Ala

A tripeptide composed of glycine, glycine and L-alanine residues joined in sequence.


Leu-Gln-Pro

A tripeptide consisting of L-leucyl, L-glutaminyl and L-proline residues joined in sequence.


Glu-Ala-Trp

A tripeptide composed of L-glutamic acid, L-alanine and L-tryptophan joined in sequence by peptide linkages.


Thr-Thr-Thr

A tripeptide composed of three L-threonine units joined by peptide linkages.


Cys-Met-Gln

A tripeptide composed of L-cysteine, L-methionine and L-glutamine joined in sequence by peptide linkages.


N-acetyl-L-tyrosylglycylglycine

A tripeptide consisting of AcTyrGlyGly.


Lys-Glu-Glu

A tripeptide composed of one L-lysine and two L-glutamic acid units joined by peptide linkages.


Thr-Pro-Tyr

A tripeptide composed of L-threonine, L-proline, and L-tyrosine joined by peptide linkages.


Cys-Gln-Gln

A tripeptide composed of one L-cysteine and two L-glutamine acid units joined by peptide linkages.


A tripeptide consisting of AcTyrGlyGly with a (4-trimethylammoniophenyl)diazenyl group at the 3-position on the tyrosine phenyl ring.


Phe-Ala-Gly

A tripeptide composed of L-phenylalanine, L-alanine, and glycine joined by peptide linkages.


Trp-Ala-Asp

A tripeptide composed of L-tryptophan, L-alanine, and L-aspartic acid joined by a peptide linkage.


A tripeptide consisting of betaAlaGlyGly with a 4-hydroxy-3-iodo-5-nitrophenylacetyl substituent on the beta-alanine nitrogen.


Glu-Phe-Val

A tripeptide composed of L-glutamic acid, L-phenylalanine and L-valine joined in sequence by peptide linkages.


Val-Asn-Pro

A tripeptide composed of L-valine, L-asparagine, and L-proline joined by peptide linkages.


Phe-Pro-Pro

A tripeptide composed of L-phenylalanine and two L-proline units joined by peptide linkages.


Glu-Glu-Ile

A tripeptide composed of two L-glutamic acid units and L-isoleucine joined in sequence by peptide linkages.


Glu-Asp-Asp

A tripeptide composed of one L-glutamic acid and two L-aspartic acid units joined in sequence by peptide linkages.


Asp-Gln-Ser

A tripeptide composed of L-aspartic acid, L-glutamine and L-serine joined in sequence by peptide linkages.


Thr-Ala-Asp

A tripeptide composed of L-threonine, L-alanine, and L-aspartic acid joined by peptide linkages.


Ala-Cys-Gly

A tripeptide composed of L-alanine, L-cysteine, and glycine joined in sequence by peptide linkages.


glycyl-glycyl-glycine

A tripeptide in which three glycine units are linked via peptide bonds in a linear sequence.


Val-Ala-Lys

A tripeptide composed of L-valine, L-alanine and L-lysine residues joined in sequence.


Trp-Trp-Val

A tripeptide composed of two L-tryptophan and one L-valine residues joined by peptide linkages.


Gly-His-Lys

A tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence.


Asp-Gly-Glu

A tripeptide composed of L-aspartic acid, glycine, and L-glutamic acid units joined in sequence.


Leu-Thr-Gln

A tripeptide composed of L-leucine, L-threonine and L-glutamine joined in sequence by peptide linkages.


Leu-Thr-Ser

A tripeptide composed of L-leucine, L-threonine and L-serine joined in sequence by peptide linkages.


Glu-Glu-Lys

A tripeptide containing two L-glutamic acid residues and an L-lysine residue joined in sequence.


Leu-Asn-His

A tripeptide composed of L-leucine, L-asparagine and L-histidine joined in sequence by peptide linkages.


Ser-Leu-Ser

A tripeptide formed from L-serine, L-leucine and L-serine residues joined in sequence by peptide linkages.


Lys-Lys-Leu

A tripeptide composed of two L-lysine units and L-leucine joined in sequence by peptide linkages.


Ala-Ala-Gly

A tripeptide composed of two L-alanine units and a glycine joined by peptide linkages.


bilanafos

A tripeptide comprising one L-phosphinothricyl and two L-alanyl units joined in sequence.


Met-Phe-Met

A tripeptide consisting of L-methionine, L-phenylalanine and L-methionine residues joined in sequence by peptide linkages.


Leu-Phe-Asp

A tripeptide composed of L-leucine, L-phenylalanine and L-aspartic acid joined in sequence by peptide linkages.


Lys-Glu-Thr

A tripeptide composed of L-lysine, L-glutamic acid and L-threonine joined in sequence by peptide linkages.


Glu-Glu-Gly

A tripeptide composed of two L-glutamic acid and one glycine residues joined in sequence.


cryptomaldamide

A hybrid tripeptide from the marine cyanobacterium Moorea producens.


Leu-Leu-Gly

A tripeptide composed of two L-leucine units and glycine joined in sequence by peptide linkages.


Leu-Leu-Asn

A tripeptide composed of two L-leucine units joined to L-asparagine by a peptide linkage.


Ala-Gln-Pro

A tripeptide composed of L-alanine, L-glutamine, and L-proline joined in sequence by peptide linkages.


boceprevir

A synthetic tripeptide consisting of N-(tert-butylcarbamoyl)-3-methyl-L-valyl, a cyclopropyl-fused prolyl and 3-amino-4-cyclobutyl-2-oxobutanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection.


Thr-Ala-Ala

A tripeptide composed of L-threonine and two L-alanine units joined by peptide linkages.


Gly-Ala-Ala

A tripeptide composed of glycine, L-alanine and L-alanine residues joined in sequence by peptide linkages.


D-Ala-Gly-Gly

A tripeptide composed of one D-alanine and two glycine residues joined in sequence.


Val-Pro-Pro

A tripeptide composed of L-valine and two L-proline units joined by peptide linkages.


Arg-Asp-Asp

A tripeptide composed of one L-arginine and two L-aspartic acid units joined in sequence by peptide linkages.


NBD-N(Me)-DKbetaA-OH

A tripeptide comprising in sequence alpha-aspartyl, lysyl residue and beta-alanyl residues, to the nitrogen of the aspartyl residue of which are linked both a methyl group and a 7-nitro-2,1,3-benzoxadiazol-4-yl moiety.


Pro-Arg-Pro

A tripeptide composed of L-proline, L-arginine and L-proline joined in sequence by peptide linkages.


Lys-Leu-Ser

A tripeptide composed of L-lysine, L-leucine and L-serine joined in sequence by peptide linkages.


Ala-Asp-Ser

A tripeptide composed of L-alanine, L-aspartic acid, and L-serine joined in sequence by peptide linkages.


TRH

A tripeptide composed of L-pyroglutamyl, L-histidyl and L-prolinamide residues joined in sequence.


Arg-Trp-Pro

A tripeptide composed of L-arginine, L-tryptophan and L-proline joined in sequence by peptide linkages.


Trp-Asp-Ser

A tripeptide composed of L-tryptophan, L-aspartic acid, and L-serine joined by peptide linkages.


Glu-Arg-Gly

A tripeptide composed of L-glutamic acid, L-arginine, and glycine joined in sequence by peptide linkages.


Met-Ala-Asp

A tripeptide composed of L-methionine, L-alanine and L-aspartic acid joined in sequence by peptide linkages.


Met-Ala-Met

A tripeptide composed of L-methionine, L-alanine, and L-methionine joined in sequence by peptide linkages.


Leu-Thr-Asp

A tripeptide composed of L-leucine, L-threonine and L-aspartic acid joined in sequence by peptide linkages.


Phe-Asp-Cys

A tripeptide composed of L-phenylalanine, L-aspartic acid, and L-cysteine joined by peptide linkages.


Gly-Phe-Phe

A tripeptide composed of one glycine and two L-phenylalanine residues joined in sequence


Leu-Val-Gly

A tripeptide composed of L-leucine, L-valine and glycine joined in sequence by peptide linkages.


Glu-Glu-Arg

A tripeptide composed of two L-glutamic acid residues and an L-arginine residue joined in sequence.


Lys-Tyr-Glu

A tripeptide composed of L-lysine, L-tyrosine and L-glutamic acid joined in sequence by peptide linkages.


glutathione S-sulfinate

An S-substituted glutathione that is glutathione in which the mercapto hydrogen has been replaced by a sulfinyl group.


Trp-Leu-Leu

A tripeptide composed of L-tryptophan, L-leucine, and L-leucine joined by peptide linkages.


Asp-Gly-Pro

A tripeptide composed of L-aspartic acid, glycine, and L-proline units joined in sequence.


Thr-Ala-Ser

A tripeptide composed of L-threonine, L-alanine, and L-serine joined by peptide linkages.


Ala-Asp-Pro

A tripeptide composed of L-alanine, L-aspartic acid, and L-proline units joined in sequernce by peptide linkages.


Leu-Asp-Gly

A tripeptide composed of L-leucine, L-aspartic acid and glycine joined in sequence by peptide linkages.


Glu-Gly-Trp

A tripeptide composed of L-glutamic acid, glycine and L-tryptophan joined in sequence by peptide linkages.


Gly-Arg-Pro

A tripeptide composed of glycine, L-arginine and L-proline joined in sequence by peptide linkages.


A tripeptide consisting of betaAlaGlyGly with a 2,4,6-trinitrophenyl) substituent on the nitrogen of beta-alanine.


Ala-Ala-Asp

A tripeptide composed of two L-alanyl and an L-aspartic acid residue joined in sequence.


Gly-Gly-Ile

A tripeptide composed of glycine, glycine and L-isoleucine residues joined in sequence.


Gly-Gly-D-Leu

A tripeptide composed of glycine, glycine and D-leucine residues joined in sequence.


Thr-Ser-His

A tripeptide composed of L-threonine, L-serine and L-histidine residues joined in sequence.


Tyr-Ile-Leu

A tripeptide composed of L-tyrosine, L-isoleucine, and L-leucine joined in sequence by peptide linkages.


Thr-Trp-Asp

A tripeptide composed of L-threonine, L-tryptophan, and L-aspartic acid joined by peptide linkages.


Gly-Gly-Phe

A tripeptide composed of glycine, glycine and L-phenylalanine residues joined in sequence.


DNP-N-GKbetaA-OH

A tripeptide comprising in sequence glycyl, lysyl and beta-alanyl residues, to the nitrogen of the glycyl residue of which is linked a 2,4-dinitrophenyl moiety.


A tripeptide comprising N(2)-acetyl-D-glutamic acid, L-histidine and D-prolinamide residues coupled in sequence.


Glu-Gly-Phe

A tripeptide consisting of L-glutamic acid, glycine and L-phenylalanine residues joined in sequence.


Leu-Leu-Leu

A tripeptide formed from three L-leucine residues.


3,4-dimethylphenyl isocyanate

An isocyanate that consists of phenyl isocyanate bearing two additional methyl substituents at positions 3 and 4.


CORDYHEPTAPEPTIDE A

A homodectic cyclic peptide made up from N-methylglycyl, L-phenylalanyl, N-methyl-L-tyrosyl, L-isoleucyl, L-leucyl, N-methyl-D-phenylalanyl and L-prolyl residues linked in sequence. It is an antimalarial drug isolated from the insect pathogenic fungus Cordyceps.


An amino trisaccharide consisting of alpha-L-rhamnose at the reducing end having an alpha-L-rhamnosyl-(1->3)-N-acetyl-beta-D-glucosaminyl moiety attached at the 2-position.


sodium metaborate

An inorganic sodium salt having metaborate as the counterion.


alkynyllithium compound

An organolithium compound where an alkynyl group is bound to a lithium atom.


ethynyllithium

An alkynyllithium compound resulting from the replacement of one of the hydrogens of acetylene by lithium.


A univalent carboacyl group derived from 11alpha-hydroxyprogesterone hemisuccinate.


beta-D-xylofuranose

A D-xylose that is the furanose form of xylose which has beta- configuration at the anomeric centre.


3'-(L-glutamate)adenylyl(1-) group

An organic anionic group obtained by deprotonation of the phosphate and carboxy functions as well as protonation of the amino function of 3'-(L-glutamyl)adenylyl group; major species at 7.3.


Congo Red

An indicator dye that is blue-violet at pH 3.0 and red at pH 5.0.


An N-acylsphingosine in which the ceramide N-acyl group is specified as 30-[(9Z,12Z)-octadeca-9,12-dienoyloxy]triacontanoyl.


yttrium-89 atom

The stable isotope of yttrium with relative atomic mass 88.905848, 100 atom percent natural abundance and nuclear spin 1/2.


An organofluorine compound that is 3-phenylpropan-1-ol bearing a trifluoromethyl group at position 3 on the phenyl ring.


An L-alpha-amino acid residue derived from N(4)-(N-acetyl-beta-D-glucosyl)-L-asparagine.


An N-acetylated alpha-(2->8)-linked homosialopolysaccharide consisting of eight alpha-D-N-acetylneuraminyl residues joined by (2->8) linkages (i.e. [8)-alpha-Neu5Ac-(2->]n where n = 8).


An amino oligosaccharide consisting of repeating units of N-acetylneuraminic acid that are joined via alpha-(2->8)-linkages. Commonly known as polysialic acid or PSA,


An N-acetylated alpha-(2->8)-linked homosialopolysaccharide consisting of five alpha-D-N-acetylneuraminyl residues joined by (2->8) linkages (i.e. [8)-alpha-Neu5Ac-(2->]n where n = 5).


An N-acetylated alpha-(2->8)-linked homosialopolysaccharide consisting of six alpha-D-N-acetylneuraminyl residues joined by (2->8) linkages (i.e. [8)-alpha-Neu5Ac-(2->]n  where n = 6).


A beta-D-glucoside having a malonyl group at the 6-position and a 3-O-delphinidin moiety at the anomeric position.


EUPATORIN

A trimethoxyflavone that is 6-hydroxyluteolin in which the phenolic hydogens at positions 4', 6 and 7 have been replaced by methyl groups.


A fifteen-membered glycopeptide comprising glycyl, isoleucyl, alanyl, glycyl, tyrosyl, (5R)-5-(beta-D-galactopyranosyloxy)lysyl, glycyl. alpha-glutamyl, glutaminyl, glycyl, prolyl, lysyl, glycyl, alpha-glutamyl and threonine residues coupled in sequence.


D-norleucine zwitterion

A D-alpha-amino acid zwitterion arising from the transfer of a proton from the carboxy to the amino group of D-norleucine; major species at pH 7.3.


N-terminal N-acetyl-L-alanine residue

An N-terminal alpha-amino-acid residue derived from N-terminal N-acetyl-L-alanine.


An amino tetrasaccharide consisting of alpha-D-galactose, beta-D-galactose, N-acetyl-beta-D-glucosamine and N-acetyl-beta-D-galactosamine residues connected in sequence by (1->3) linkages.


The 2-aminoethyl glycoside of an amino decasaccharide made of two alpha-L-Rhap-(1->2)-alpha-L-Rhap-(1->3)-[alpha-D-Glcp-(1->4)]-alpha-L-Rhap-(1->3)-beta-D-GlcpNAc repeating units of the Shigella flexneri serotype 2a specific polysaccharide linked (1->2) and with the rhamnose residue four residues from the reducing end the N-acetylglucosamine residue five residues from the reducing end acetylated on O-3 and O-6 respectively.


postsynaptic cytosol

category: biolink:CellularComponent biolink:AnatomicalEntity biolink:PhysicalEssence biolink:OrganismalEntity biolink:SubjectOfInvestigation biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: The region of the cytosol consisting of all cytosol that is part of the postsynapse.


cytosolic region

description: Any (proper) part of the cytosol of a single cell of sufficient size to still be considered cytosol.


presynaptic cytosol

description: The region of the cytosol consisting of all cytosol that is part of the presynapse.


An O-(S-acylpantetheine-4'-phosphoryl)serine(1-) residue in which the S-acyl group is specified as 4,5-dibromopyrrole-2-carbonyl.


octasaccharide derivative

An oligosaccharide derivative that is formally obtained from an octasaccharide.


A branched amino octasaccharide comprised of a backbone of N-acetyl-beta-D-glucosaminyl, alpha-D-mannosyl, beta-D-mannosyl, N-acetyl-beta-D-glucosaminyl and N-acetyl-beta-D-glucosamine residues linked in sequence (1->2), (1->3), (1->4) and (1->4), to the beta-D-mannosyl residue is also linked (1->2) a beta-D-xylosyl residue, while to the N-acetyl-beta-D-glucosamine residue at the reducing end are also linked (1->3) and (1->6) alpha-L-fucosyl residues.


A branched amino octasaccharide made up from four N-acetyl-beta-D-glucosamine residues, two alpha-D-mannose residues, one beta-D-mannose residue and (at the reducing end) one N-acetyl-D-glucosamine residue.


An amino octasaccharide in which an N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl disaccharide chain and a beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl chain are linked (1->6) and (1->3) respectively to the mannose residue of a beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-D-glucosamine trisaccharide.


A heparin octasaccharide consisting of 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-2-O-sulfo-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-2-O-sulfo-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-2-O-sulfo-D-xylo-hexopyranuronosyl, and 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DHexA-GlcNSO3-HexA(2SO4)-GlcNSO3-HexA(2SO4)-GlcNSO3-HexA(2SO4)-GlcNSO3.


An amino octasaccharide comprising two acetylated glucosamine residues and six alpha-L-rhamnose residues, one of which is at the reducing end.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-GlcNAc-(1->2)-[beta-D-GlcNAc-(1->6)]-alpha-D-Man group, while the beta-D-GlcNAc residue at the reducing end carries two alpha-L-Fuc residues via (1->3) and (1->6) linkages.


A heparin octasaccharide consisting of 4-deoxy-2-O-sulfo-L-threo-hex-4-enopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-D-glucopyranosyl, 2-O-sulfo-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-D-glucopyranosyl, 2-O-sulfo-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-D-glucopyranosyl, 2-O-sulfo-L-idopyranuronosyl, and 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose joined in sequence by alpha-(1->4) linkages. Sequence: DUAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S.


A linear amino octasaccharide comprised of beta-D-galactose, N-acetyl-beta-D-glucosamine, beta-D-galactose, N-acetyl-beta-D-glucosamine, beta-D-galactose, N-acetyl-beta-D-glucosamine, beta-D-galactose and D-glucose residues linked sequentially (1->4), (1->3), (1->4), (1->3), (1->4), (1->3) and (1->4). It is found in human milk.


heparin octasaccharide

Any amino octasaccharide obtained by either chemical or enzymatic cleavage of the polymeric glycosaminoglycan heparin.


A branched amino octasaccharide comprising a sequence of alpha-sialyl, beta-D-galactosyl, N-acetyl-beta-D-glucosaminyl, alpha-D-mannosyl, beta-D-mannosyl, N-acetyl-beta-D-glucosaminyl and N-acetyl-D-glucosamine residues linked respectively (2->6), (1->4), (1->2), (1->3), (1->4) and (1->4), to the beta-D-mannosyl residue of which is also linked (1->6) a further alpha-D-mannosyl residue.


A branched amino octasaccharide that consists of the linear tetrasaccharide beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Gal in which the beta-D-Gal residue is substituted at position 6 by a beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc group. It is found in human milk.


A branched amino octasaccharide consisting of a beta-D-GlcNAc residue at the reducing end with a beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)-[alpha-D-Man-(1->3)]-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc moiety attached via a beta-(1->4)-linkage.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by an alpha-D-Man-(1->6)-alpha-D-Man group, while the D-GlcNAc residue at the reducing end is substituted at position 6 by an alpha-L-Fuc residue.


A heparin octasaccharide consisting of 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, beta-D-glucopyranuronosyl, and 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DUA2S-GlcNS6S-IdoA2S-GlcNS6S-IdoA2S-GlcNS6S-GlcA-GlcNS6S.


A branched octasaccharide derivative comprising one 5-deoxy-5-(methylsulfanyl)xylofuranose, one mannopyranose and six D-arabinofuranose units, in an assembly consisting of two of the arabinose residues linked alpha(1->5), with beta-arabinosyl-(1->2)-alpha-arabinosyl and 5-deoxy-5-(methylsulfanyl)-beta-xylofuranosyl-(1->4)-alpha-mannosyl-(1->5)-beta-arabinosyl-(1->2)-alpha-arabinosyl units linked to respectively the 3- and 5-positions of the arabinose residue distal from the reducing-end residue.


A branched amino octasaccharide comprised of a sequence of alpha-D-mannose, beta-D-mannose, N-acetyl-beta-D-glucosamine and N-acetyl-D-glucosamine residues linked (1->3), (1->4) and (1->4), to the beta-D-mannose of which is (1->6)-linked a tetrasaccharide branch comprising N-acetyl-alpha-neuraminose, beta-D-galactose, N-acetyl-beta-D-glucosamine and alpha-D-mannose residues linked sequentially (2->6), (1->4) and (1->2).


A branched amino octasaccharide comprising a linear hexasaccharide of beta-D-galactose, N-acetyl-beta-D-glucosamine, N-acetyl-beta-D-galactosamine, alpha-D-galactose, beta-D-galactose and D-glucose residues linked sequentially (1->4), (1->6), (1->3), (1->4) and (1->4), to the GlcNac and GalNAc residues of which are also (1->3) linked alpha-L-galactose and beta-D-galactose residues respectively.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc in which the mannosyl group is substituted at positions 3 and 6 by beta-D-GlcNAc-(1->2)-alpha-D-Man groups and the reducing-end N-acetyl-beta-D-glucosamine residue is substituted at position 6 by an alpha-L-fucosyl group.


A branched amino octasaccharide comprised of a backbone of beta-D-galactosyl, N-acetyl-beta-D-glucosaminyl, alpha-D-mannosyl, beta-D-mannosyl, N-acetyl-beta-D-glucosaminyl and N-acetyl-beta-D-glucosamine residues linked in sequence (1->4), (1->2), (1->3), (1->4) and (1->4), to the beta-D-mannosyl residue is also linked (1->2) a beta-D-xylosyl residue, while to the beta-D-GlcNAc residue at the reducing end is also linked (1->6) an alpha-L-fucosyl residue.


A branched amino octasaccharide that consists of the linear tetrasaccharide beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc in which the beta-D-Gal residue is substituted at position 6 by a beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc group. It is found in human milk.


A heparan sulfate octasaccharide with sequence: GlcA-GlcNSO3-IdoA(2-OSO3)-GlcNSO3-IdoA(2-OSO3)-GlcNSO3-IdoA-aManR(6-OSO3) (aManR = 2,5-anhydro-D-mannitol).


A branched octasaccharide derivative comprising one 5-deoxy-5-(methylsulfanyl)xylofuranose, one mannopyranose and six D-arabinofuranose units, in an assembly consisting of two of the arabinose residues linked alpha(1->5), with 5-deoxy-5-(methylsulfanyl)-beta-xylofuranosyl-(1->4)-alpha-mannosyl-(1->5)-beta-arabinosyl-(1->2)-alpha-arabinosyl and beta-arabinosyl-(1->2)-alpha-arabinosyl units linked to respectively the 3- and 5-positions of the arabinose residue distal from the reducing-end residue.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by an alpha-D-Man-(1->3)-alpha-D-Man group, while the D-GlcNAc residue at the reducing end is substituted at position 6 by an alpha-L-Fuc residue.


An amino octasaccharide comprising two units, linked (1->2), of an amino tetrasaccharide, each unit consisting of 4-deoxy-4-formamido-beta-D-quinovose residue, two 2-acetamido-2-deoxy-alpha-D-galacturonamide residues and an N-acetyl-beta-D-quinovosamine residue linked in a (1->4), (1->4), (1->3) sequence.


A heparin octasaccharide consisting of 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, alpha-L-idopyranuronosyl, 2-acetamido-2-deoxy-6-O-sulfo-alpha-D-glucopyranosyl, beta-D-glucopyranuronosyl, and 2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DUA2S-GlcNS6S-IdoA2S-GlcNS6S-IdoA-GlcNAc6S-GlcA-GlcNS3S6S.


A branched amino octasaccharide compound consisting of a beta-D-GlcNAc residue at the reducing end with a Man-alpha(1->3)-[Man-alpha(1->6)-Man-alpha(1->6)]-Man-beta(1->4)-GlcNAc moiety attached via a beta-(1->4)-linkage and two Fuc residues attached via alpha-(1->3)- and alpha-(1->6)-linkages.


An amino octasaccharide that is the linear hexasaccharide alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc in which the mannosyl residue nearest the reducing end has the disaccharide alpha-D-Man-(1->3)-alpha-D-Man attached at position 6.


A heparin octasaccharide consisting of 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, and 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DHexA-GlcNSO3-HexA-GlcNSO3(6SO4)-HexA-GlcNSO3-HexA-GlcNSO3.


An amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc in which the mannosyl group is substituted at positions 3 and 6 by beta-D-GlcNAc-(1->2)-alpha-D-Man groups and the GlcNAc residue at the reducing end is substituted at position 6 by an alpha-L-Fuc residue.


An amino octasaccharide consisting of two beta-D-galactosyl-(1->3)-N-acetyl-D-galactosamine disaccharide units linked beta(1->3), to each galactosyl residue of which is linked beta(1->6) a pseudaminyl-(2->6)-D-glucosyl branch. The molecule represents two of the repeat units of the exopolysaccharide of the the Gram negative pathogen Acinetobacter baumannii strain 54149, of which the majority of the repeat units contain the aforementioned linked pseudaminic acid moiety (PMID:29965749).


A heparin octasaccharide consisting of 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, and 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DHexA-GlcNSO3-HexA-GlcNSO3(6SO4)-HexA-GlcNSO3(6SO4)-HexA-GlcNSO3(6SO4).


A branched amino octasaccharide that consists of the linear tetrasaccharide beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc in which the beta-D-Gal residue is substituted at position 6 by a beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc group. It is found in human milk.


A branched amino octasaccharide comprising a linear pentasaccharide chain of N-acetyl-alpha-neuraminyl, beta-D-galactosyl, N-acetyl-beta-D-glucosaminyl, beta-D-galactosyl and D-glucose residues linked sequentially (2->6), (1->4), (1->6) and (1->4), to the galactose residue nearer to the reducing end is also linked (1->3) a linear alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl trisaccharide unit.


A branched amino octasaccharide made up from three galactose residues, two N-acetylglucosamine residues, one glucose residue and two fucose residues.


An amino ctasaccharide that is alpha-L-Fuc-(1->3)-[beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)]-GlcNAc in which the mannosyl group is substituted at positions 3 and 6 by beta-D-GlcNAc-(1->2)-alpha-D-Man groups.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by an alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man group.


An eight-membered glucosamine oligosaccharide that consists of the disaccharide beta-D-Gal-(1->4)-beta-D-Glc, to the glucose residue of which are attached alpha-L-Fuc-(1->4)-[alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)]-beta-D-GlcNAc and beta-D-Gal-(1->4)-beta-D-GlcNAc groups at O-3 and O-6 respectively.


A branched amino octasaccharide consisting of a beta-D-GlcNAc residue at the reducing end with a beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc moiety attached via a beta-(1->4)-linkage.


An amino octasaccharide comprising three D-GlcNS(6S) residues, one D-GlcNS(6S) residue, two D-GlcA(2S) residues and two D-GlcA residues (with one at the reducing end joined to 4-nitrophenol via a glycosidic linkage).


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc in which the mannosyl group is substituted at position 6 by a beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 3 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group.


An amino octasaccharide consisting of four beta-D-galactopyranosyl-(1->4)-beta-D-N-acetylglucosamine disaccharides linked together by (1->3) glycosidic linkage, but with beta-D-glucopyranose replacing beta-D-N-acetylglucosamine as the terminal monosaccharide.


A heparin octasaccharide consisting of 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-2-O-sulfo-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-2-O-sulfo-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, and 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DHexA-GlcNSO3-HexA(2SO4)-GlcNSO3-HexA(2SO4)-GlcNSO3-HexA-GlcNSO3.


A heparin octasaccharide consisting of 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-2-O-sulfo-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, and 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DHexA-GlcNSO3-HexA(2SO4)-GlcNSO3-HexA-GlcNSO3-HexA-GlcNSO3.


A branched amino octasaccharide consisting of a pentasaccharide chain of N-acetyl-beta-D-glucosamine, alpha-D-mannose, beta-D-mannose and two further N-acetyl-beta-D-glucosamine residues linked sequentially (1->2), (1->3), (1->4) and (1->4), to the beta-D-mannose residue of which is also linked (1->6) an N-acetyl-beta-D-glucosaminyl-(1->2)-[N-acetyl-beta-D-glucosaminyl-(1->6)]-alpha-D-mannosyl trisaccharide unit.


A branched amino octasaccharide consisting of alpha-D-mannose, beta-D-mannose and two N-acetyl-beta-D-glucosamine residues linked sequentially (1->6), (1->4) and (1->4), to the alpha-D-mannose residue of which are linked (1->3) and (1->6) two further alpha-D-mannose residues and to the beta-D-mannose residue of which is (1->3)-linked also an alpha-D-mannose residue. The N-acetyl-beta-D-glucosamine residue at the reducing end carries also an alpha-L-fucosyl residue via a (1->3) linkage.


A heparin octasaccharide consisting of 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, and 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DHexA-GlcNSO3-HexA-GlcNSO3(6SO4)-HexA-GlcNSO3(6SO4)-HexA-GlcNSO3.


A branched amino octasaccharide consisting of a beta-D-GlcNAc residue at the reducing end with a beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc moiety attached via a beta-(1->4)-linkage.


amino octasaccharide

An octasaccharide derivative having one or more substituted or unsubstituted amino groups in place of hydroxy groups at unspecified positions.


A heparin octasaccharide consisting of 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, and 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DUA2S-GlcNS6S-IdoA2S-GlcNS6S-IdoA2S-GlcNS6S-IdoA2S-GlcNS.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group.


A branched amino octasaccharide consisting of alpha-D-mannose, beta-D-mannose and two N-acetyl-beta-D-glucosamine residues linked sequentially (1->6), (1->4) and (1->4), to the alpha-D-mannose residue of which are linked (1->3) and (1->6) two further alpha-D-mannose residues and to the beta-D-mannose residue of which is (1->3)-linked an alpha-D-mannosyl-(1->2)-alpha-D-mannose unit.


A branched amino octasaccharide correspnding to the inner core and outer core moieties of the bacterial O-SP--core antigen of Vibrio cholerae O1, serotype Ogawa.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group.


A linear amino octasaccharide comprised of beta-D-galactose, N-acetyl-beta-D-glucosamine, beta-D-galactose, N-acetyl-beta-D-glucosamine, beta-D-galactose, N-acetyl-beta-D-glucosamine, beta-D-galactose and D-glucose residues linked sequentially (1->3), (1->3), (1->4), (1->3), (1->4), (1->3) and (1->4). It is found in human milk.


A branched amino octasaccharide consisting of a D-GlcNAc residue at the reducing end with a beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)-[alpha-D-Man-(1->3)]-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc moiety attached via a beta-(1->4)-linkage and an L-Fuc residue attached via an alpha-(1->3)-linkage.


A branched amino octasaccharide that is beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc in which the hydroxy groups at positions 2, 3 and 6 of the mannosyl residue have been glycosylated by a beta-D-xylopyranosyl residue, an N-acetyl-beta-D-glucopyranosaminyl-(1->2)-alpha-D-mannopyranosyl group and an alpha-D-mannopyranosyl residue respectively, while the GlcNAc residue at the reducing end carries also an alpha-L-fucosyl residue attached via a (1->3)-linkage.


A branched amino octasaccharide consisting of a linear hexasaccharide comprising beta-D-galactose, N-acetyl-beta-D-galactosamine and beta-D-galactose residues, two L-glycero-alpha-D-manno-heptose (L-alpha-D-Hep) residues and a 3-deoxy-alpha-D-manno-oct-2-ulose (alpha-Kdo) residue linked in sequence (1->3), (1->4), (1->3), (1->3) and (1->5), to the L-alpha-D-Hep residue proximal to the reducing end is also linked (1->4) a beta-D-glucose residue, while the alpha-Kdo residue also carries a second alpha-Kdo residue linked (2->-4). One of a number of chemoenzymatically synthesised oligosaccharides composed of the inner core oligosaccharide of Campylobacter jejuni extended by various ganglioside mimics.


A heparan sulfate octasaccharide with sequence: GlcA-GlcNSO3(6-OSO3)-IdoA(2-OSO3)-GlcNSO3-IdoA(2-OSO3)-GlcNSO3-IdoA-aManR(6-OSO3) (aManR = 2,5-anhydro-D-mannitol).


A branched amino octasaccharide comprised of a sequence of beta-D-galactose, N-acetyl-beta-D-glucosamine, beta-D-galactose, N-acetyl-beta-D-glucosamine,beta-D-galactose and N-acetyl-beta-D-glucosamine residues, linked (1->4), (1->3), (1->4), (1->3) and (1->4), to the reducing-end and centrally positioned GlcNAc residues of which are also (1->3)-linked alpha-L-fucose residues.


A heparin octasaccharide consisting of 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranosyl, (5xi)-D-xylo-hexopyranuronosyl, and 2-deoxy-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages.  Sequence: DHexA-GlcNSO3-HexA-GlcNSO3-HexA-GlcNSO3-HexA-GlcNSO3.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by a beta-D-GlcNAc-(1->2)-[beta-D-GlcNAc-(1->6)]-alpha-D-Man group.


A branched amino octasaccharide consisting of a beta-D-GlcNAc residue at the reducing end with an alpha-D-Man-(1->6)-[beta-D-Xyl-(1->2)]-[alpha-D-Man-(1->3)]-beta-D-Man-(1->4)-beta-D-GlcNAc moiety attached via a (1->4)-linkage and alpha-L-Fuc residues attached via (1->3) and (1->6) linkages.


An amino octasaccharide comprising four D-GlcNS residues, two D-GlcA(2S) residues and two D-GlcA residues (with one at the reducing end joined to 4-nitrophenol via a glycosidic linkage).


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by an alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man group.


A branched amino octasaccharide comprised of a backbone of N-acetyl-beta-D-galactosaminyl, N-acetyl-beta-D-glucosaminyl, alpha-D-mannosyl, beta-D-mannosyl, N-acetyl-beta-D-glucosaminyl and N-acetyl-beta-D-glucosamine residues linked in sequence (1->4), (1->2), (1->3), (1->4) and (1->4), to the beta-D-mannosyl residue is also linked (1->2) a beta-D-xylosyl residue, while to the D-GlcNAc residue at the reducing end is also linked (1->3) an alpha-L-fucosyl residue.


A branched amino octasaccharide derivative that is beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc in which the mannosyl group is substituted at position 3 by a beta-D-GlcNAc-(1->2)-alpha-D-Man group and at position 6 by an alpha-D-Man-(1->3)-alpha-D-Man group, while the D-GlcNAc residue at the reducing end is substituted at position 6 by an alpha-L-Fuc residue.


A linear synthetic octasaccharide derivative consisting of eight D-glycero-alpha-D-manno-heptopyranose residue linked in sequence (1->3), (1->3), (1->3), (1->3), (1->6),(1->2), (1->2). An aminopropyl linker at the reducing end enables printing onto microscope slides.  One of a series of substructures of the Helicobacter pylori O6 O-antigen tridecasaccharide O-antigen used for its immunological evaluation.


A branched amino octasaccharide consisting of a linear hexasaccharide chain of alpha-D-galactose, N-acetyl-beta-D-glucosamine, beta-D-galactose, beta-D-glucose, L-glycero-alpha-D-manno-heptose (Hep) and 3-deoxy-D-manno-oct-2-ulose (Kdo) residues linked in a (1->4), (1->3), (1->4), (1->4), (1->5) sequence, to the Hep residue of which is linked (1->3) an N-acetyl-alpha-D-glucosaminyl-(1->2)-L-glycero-alpha-D-manno-heptosyl side-chain. lpt3 mutant of the core oligosaccharide of Neisseria meningitidis.


An octasaccharide derivative composed of a 5-deoxy-5-(methylsulfanyl)xylofuranose, three mannopyranose and four arabinofuranose residues in an alpha(1->4), alpha(1->2), alpha(1->2), alpha(1->5), beta(1->2), alpha(1->5) and alpha(1->5) linear sequence.


A heparan sulfate octasaccharide with sequence: GlcA-GlcNSO3(6-OSO3)-IdoA(2-OSO3)-GlcNSO3(6-OSO3)-IdoA(2-OSO3)-GlcNSO3-IdoA-aManR (aManR = 2,5-anhydro-D-mannitol).


A heparan sulfate octasaccharide with sequence: GlcA-GlcNSO3-IdoA(2-OSO3)-GlcNSO3(6-OSO3)-IdoA(2-OSO3)-GlcNSO3-GlcA-aManR (aManR = 2,5-anhydro-D-mannitol).


heparan sulfate octasaccharide

Any amino octasaccharide obtained by either chemical or enzymatic cleavage of the polymeric glycosaminoglycan heparan sulfate.


GlyTouCan G72291OX

An amino octasaccharide consisting of four hexosyl groups, three acetaminohexosyl groups and an N-acetcylneuraminic acid group (identities and connectivity unknown). Composition: Hex4 HexNAc3 Neu5Ac1.


A branched amino octasaccharide consisting of a beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-D-glucosamine trisaccharide in which the mannose residue carries N-acetyl-beta-D-glucosaminyl-(1->2)-[N-acetyl-beta-D-glucosaminyl-(1->4)]-alpha-D-mannosyl and N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl units through (1->3) and (1->6) linkages respectively.


A branched amino octasaccharide that is beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc in which the hydroxy groups at positions 2, 3 and 6 of the mannosyl residue have been glycosylated by a beta-D-xylopyranosyl residue, an N-acetyl-beta-D-glucopyranosaminyl-(1->2)-alpha-D-mannopyranosyl group and an alpha-D-mannopyranosyl residue respectively, while the GlcNAc residue at the reducing end carries also an alpha-L-fucosyl residue attached via a (1->3)-linkage.


A branched amino octasaccharide consisting of a beta-D-GlcNAc residue at the reducing end with a beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc moiety attached via a beta-(1->4)-linkage and an alpha-L-Fuc residue attached via an alpha-(1->6)-linkage.


An amino octasaccharide comprising four D-GlcNS(6S) residues, two D-GlcA(2S) residues and two D-GlcA residues (with one at the reducing end joined to 4-nitrophenol via a glycosidic linkage).


A branched amino octasaccharide consisting of a D-GlcNAc residue at the reducing end with a beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc moiety attached via a beta-(1->4)-linkage and an alpha-L-Fuc residue attached via an alpha-(1->6)-linkage.


A branched amino octasaccharide made up from two repeating (1->3)-linked N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl units that are in turn joined to N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactose via a (1->4)-linkage.


A branched amino hexasaccharide derivative that is alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc in which the two GlcNAc residues each carry an alpha-L-Fuc residue via a (1->3) linkage.


name: (7S)-7-hydroxy-C2-C8-saturated long-chain fatty acyl pantetheine-4-phosphorylserine(1-) residue

description: An O-(S-[long-chain acyl]pantetheine-4'-phosphoryl)serine(1-) residue in which the S-acyl group is an (7S)-7-hydroxy-C2-C8-saturated long-chain fatty acyl; major species at pH 7.3.


An alpha-amino-acid residue that is an L-cysteine residue in which the hydrogen attached to the sulfur is substituted by a [4-(2-carboxyethyl)-5-{[4-(2-carboxyethyl)-3-(carboxymethyl)-1H-pyrrol-2-yl]methyl}-3-(carboxymethyl)-1H-pyrrol-2-yl]methyl group.


octose

An eight-carbon monosaccharide which in its linear form contains either an aldehyde group at position 1 (aldooctose) or a ketone group at position 2 (ketooctose).


L-glycero-L-galacto-octuluronate

Major species at pH 7.3


aldooctose

An octose with a (potential) aldehyde group at one end.


ketooctose

A ketooctose is a ketone-containing octose.


alpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine in which the acyl group is acetyl. Ganglioside GM1 with an acetyl group substituting for the long fatty acid typicalof ceramide.


An alkene that is hexane carrying a double bond at position 1.


Aflatoxin B1 endo glutathione conjugate

A metabolite of aflatoxin B1


disaccharide

A compound in which two monosaccharides are joined by a glycosidic bond.


A glycosylmannose consisting of beta-D-arabinopyranose and D-mannopyranose joined in sequence by a (1->2) glycosidic bond.


A glycosylmannose consisting of alpha-D-mannopyranose having a tyvelopyranosyl residue attached via an alpha-(1->3)-linkage


A glycosyllgalactose that is the 6-O-fucoside of alpha-D-galactopyranoside.


A glycosylgalactose consisting of D-galactopyranose having an alpha-D-galactopyranosyl residue attached at the 4-position.


A disaccharide consisting of alpha-D-glucopyranose and D-arabinopyranose residues joined in sequence by a (1->3) glycosidic bond.


A glycosyl glycoside D-xylopyraonse and D-glucopyranose joined by a (1<->1) glycosidic linkage.


A glycosylarabinose consisting of beta-D-galactopyranose and L-arabinofuranose joined in sequence by a (1->3) glycosidic bond.


A glycosylarabinose consisting of D-mannopyranose and D-arabinofuranose joined in sequence by a (1->5) glycosidic bond.


A keto-disaccharide consisting of alpha,alpha-trehalose with the keto group at the 3-position.


lactobionic acid

A disaccharide formed between beta-D-galactose and D-gluconic acid.


A glycosylmannose consisting of alpha-D-galactopyranose and alpha-D-mannopyranose residues joined in sequence by a (1->3) glycosidic bond.


A glycosylgalactose consisting of beta-D-galactose having an beta-D-glucosyl residue attached at the 2-position.


An alpha-D-galactosyl-(1->2)-D-galactose in which the reducing end anomeric centre has beta-configuration.


A glycosyl galactose consisting of an alpha-D-glucopyranose residue and a beta-D-galactofuranose residue joined in sequence by a (1->2) glycosidic bond.


LACTULOSE

A synthetic galactosylfructose disaccharide used in the treatment of constipation and hepatic encephalopathy.


A beta-D-Galf-(1->3)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


An alpha-D-galactosyl-(1->2)-D-galactose in which the reducing end anomeric centre has alpha-configuration.


A glycosylmannose consisting of two D-mannopyranose residues joined by a (1->3) glycosidic bond.


A glycosylmannose consisting of a beta-D-galactopyranose residue and a D-mannopyranose residue joined in sequence by a (1->6) glycosidic bond.


A disaccharide consisting of a D-glucosyl residue in alpha-(1->4)-linkage with L-glycero-alpha-D-manno-heptose.


An L-threo-hex-4-enopyranuronosyl-(1->4)-D-GlcpNS in which both anomeric centres have beta configuration.


A beta-D-Glcp-(1->3)-D-Arap in which the carbon bearing the anomeric hydroxy group has beta configuration.


A beta-D-Galp-(1->6)-D-Manp in which the carbon bearing the anomeric hydroxy group has beta configuration.


A glycosylgalactose consisting of alpha-D-mannopyranose and D-galactopyranose residues joined in sequence by a (1->6) glycosidic bond.


A disaccharide that is L-fucopyranose in which the hydroxy group at position 3 has been converted into the corresponding beta-D-glucopyranoside.


A glycosylmannose consisting of two D-mannopyranose residues joined via an alpha-(1->6)-linkage.


A glycosylgalactose consisting of alpha-D-mannopyranose and beta-D-galactopyranose residues joined in sequence by a (1->3) glycosidic bond.


A glycosylfructose that is D-fructofuranose attached to a alpha-D-glucopyranosyl unit at position 6 via a glycosidic linkage. It is found in honey and sugarcane.


A glycosylmannose that is beta-D-mannopyranose in which the hydroxy group at position 3 has been converted into the corresponding alpha-D-mannopyranoside.


A disaccharide consisting of alpha-D-glucopyranose and D-galactopyranose residues joined in sequence by a (1->6) glycosidic bond.


A glycosylrhamnose having a galactosyl residue attached to rhamnose via a beta-(1->4)-linkage.


hexopyranosyl hexopyranoside

A disaccharide formed by a (1<->1)-glycosidic bond between two hexopyranose units.


A beta-L-Fucp-(1->4)-D-Galp in which the galactopyranose moiety has alpha- configuration at the anomeric centre.


A disaccharide that is N-acetyl-D-glucosamino-1,5-lactone in which the hydroxy group at position 5 is replaced by a 2-acetamido-2-deoxy-beta-D-glucopyranosyl group.


An alpha-D-Glcp-(1->6)-D-Galp in which the carbon bearing the anomeric hydroxy group has beta configuration.


A glycosylmannose consisting of two alpha-D-mannopyranose residues joined via a (1->3)-linkage.


A glycosylgalactose consisting of two beta-D-galactofuranosyl residues joined by a (1->6) glycosidic bond.


An alpha-D-Galf-(1->2)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


glycosylrhamnose

A disaccharide having rhamnose at the reducing end with a glycosyl residue attached at an unspecified position via a glycosidic bond.


A glycosylgalactose consisting of a D-glucopyranose residue and a beta-D-galactopyranose residue joined in sequence by a (1->2) glycosidic bond.


A glycosylgalactose consisting of alpha-D-mannopyranose and D-galactopyranose residues joined in sequence by a (1->4) glycosidic bond.


A disaccharide consisting of beta-D-galactopyranose having a D-galactopyranosyl residue attached at the 4-position via an alpha-linkage.


A glycosylgalactose consisting of beta-D-glucopyranose and alpha-D-galactopyranose residues joined in sequence by a (1->3) glycosidic bond.


A glycosylgalactose consisting of alpha-D-mannopyranose and beta-D-galacopyranose residues joined in sequence by a (1->6) glycosidic bond.


A glycosylmannose consisting of alpha-D-mannose having an alpha-D-mannosyl residue attached at the 2-position


glycosylmannose

A disaccharide having mannose at the reducing end with a glycosyl residue attached at an unspecified position via a glycosidic bond.


A disaccharide that is D-galactopyranose in which the hydroxy group at position 4 has been converted into the corresponding beta-D-mannopyranoside.


sugar dianhydride

Cyclic products of condensation of two monosaccharide molecules with the elimination of two molecules of water.


A glycosylrhamnose consisting of alpha-D-rhamnose having an alpha-D-rhamnosyl residue attached at the 3-position.


A glycosylmannose consisting of a beta-D-galactopyranose residue and a D-mannopyranose residue joined in sequence by a (1->3) glycosidic bond.


A disaccharide comprising a 3-deoxy-alpha-D-manno-oct-2-ulopyranonosonyl unit in (2->4) linkage with D-glycero-alpha-D-talo-oct-2-ulosonic acid; it is found in the core structure of bacterial lipopolysaccharides.


A glycosylgalactose comprising two D-galactose units joined via an alpha-(1->2) linkage.


A glycosylgalactose that is beta-D-galactopyranose in which the hydroxy group at position 3 has been converted into the corresponding alpha-L-arabinopyranosyl derivative.


A galactobiose comprising an alpha-D-galactopyranose residue and a D-galactopyranose residue joined via an alpha-(1->3) linkage.


A glycosyl glycoside consisting of a D-glucopyranose residue and a D-galactopyranose residue joined by a (1<->1) glycosidic bond.


A glycosylgalactose consisting of a beta-D-glucopyranose residue and a beta-D-galactofuranose residue joined in sequence by a (1->2) glycosidic bond.


glycosylarabinose

A disaccharide having arabinose at the reducing end with a glycosyl residue attached at an unspecified position via a glycosidic bond.


A glycosylarabinose consisting of beta-D-glucopyranose and alpha-L-arabinopyranose residues joined in sequence by a (1->4) glycosidic bond.


A disaccharide consisting of two L-glycero-alpha-D-manno-heptose residues joined by a(1->3)-linkage.


A glycosylgalactose that consists of beta-D-galactose having an alpha-D-galactosyl residue at the 3-position.


A glycosylgalactose comprising two beta-D-galactose units joined via a (1->6)-linkage.


hex-2-ulofuranosyl hexopyranoside

A disaccharide formed by hexopyranoside and hex-2-ulofuranose units joined by an acetal oxygen bridge from hemiacetal of hexopyranoside to the hemiketal of the hex-2-ulofuranose.


A glycosylmannose that is beta-D-mannopyranose in which the hydroxy group at position 2 has been converted into the corresponding beta-D-xylopyranosyl derivative.


A glycosylmannose consisting of alpha-D-mannopyranose having a paratopyranosyl residue attached via an alpha-(1->3)-linkage.


A glycosylmannose consisting of an beta-D-galactofuranosyl residue attached to alpha-D-mannopyranose at the 6-position.


An alpha-D-Glcp-(1->4)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


A glycosylgalactose consisting of beta-D-galactopyranose and D-galactofuranose residues joined in sequence by a (1->6) glycosidic bond.


A D-glucosyl-D-mannose with the two components joined by an alpha-(1->6)-linkage.


A glycosylgalactose consisting of a beta-D-galactofuranose residue and a D-galactopyranose residue joined in sequence by a (1->3) glycosidic bond.


A glycosylarabinose consisting of aldehydo-D-arabinose having a beta-D-galactopyranosyl residue at the 3-position.


A glycosylmannose consisting of an alpha-D-mannopyranose residue and a D-mannopyranose residue joined in sequence by a (1->4) glycosidic bond.


A disaccharide that is alpha-D-arabinopyranose in which the hydroxy group at position 2 has been converted into the corresponding beta-D-glucoside.


A glycosylgalactose consisting of beta-L-fucopyranose and D-galactopyranose residues joined in sequence by a (1->3) glycosidic bond.


A sugar dianhydride obtained by the condensation of two units of beta-D-fructofuranose.


A disaccharide comprising 3-deoxy-alpha-D-manno-oct-2-ulopyranose (Kdo-CH2OH) having a 3-deoxy-alpha-D-manno-oct-2-ulopyranonosyl (Kdo) residue attached at the 4-position.


Published in DOI:10.1021/ja01590a031


A glycosyl glycoside consisting of a beta-D-glucopyranose residue and a D-glucitol residue joined in sequence by a (1->3) glycosidic bond.


A glycosylmannose that is beta-D-mannopyranose in which the hydroxy group at position 2 has been converted into the corresponding alpha-D-mannopyranoside.


A glycosylgalactose consisting of an alpha-L-fucopyranose residue and a D-galactopyranose residue joined in sequence by a (1->3) glycosidic bond.


Major species at pH 7.3.


A disaccharide that is D-galactopyranose in which the hydroxy group at position 3 has been converted into the corresponding beta-D-galactopyranoside.


An L-threo-hex-4-enopyranuronosyl-(1->4)-D-GlcpNS in which both anomeric centres have alpha configuration.


A glycosylgalactose consisting of a beta-D-galactofuranose residue and a D-galactofuranose residue joined in sequence by a (1->2) glycosidic bond.


A beta-D-galactopyranosyl-(1->4)-D-galactopyranose with a beta-configuration at the reducing-end anomeric centre.


A beta-D-Galf-(1->2)-D-Galf in which the carbon bearing the anomeric hydroxy group has beta configuration.


A glycosylgalactose consisting of beta-D-glucopyranose and D-galactopyranose residues joined in sequence by a (1->4) glycosidic bond.


A galactobiose that is alpha-D-galactopyranose in which the hydroxy group at position 4 has been converted into the corresponding beta-D-galactofuranoside.


A glycosylgalactose consisting of D-glucopyranose and D-galactopyranose residues joined in sequence by a (1->2) glycosidic bond.


A disaccharride consisting of beta-D-xylopyranose and alpha-D-mannopyranose joined in sequence by a (1->3) glycosidic bond.


A disaccharide consisting of two 3-deoxy-alpha-D-manno-oct-2-ulopyranonosyl units joined via an alpha-(2->8)-linkage.


A glycosylmannose consisting of D-mannose having an alpha-D-mannosyl residue attached at the 2-position.


A glycosylgalactose consisting of alpha-D-glucopyranose and D-galactopyranose joined in sequence by a (1->4) glycosidic bond.


inulobiose

A glycosyl glycoside comprising D-fructose attached to a D-fructofuranosyl residue via a beta-(2->1)-linkage.


epimelibiose

A alpha-D-Manp-(1->6)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


A disaccharide consisting of L-threo-hex-4-enopyranuronose and 2-(sulfoamino)-D-glucopyranose residues joined in sequence by a (1->4) glycosidic bond.


A glycosylmannose consisting of an beta-D-galactosyl residue attached to alpha-D-mannose at the 3-position.


A keto-disaccharide that is beta-D-galactosyl-(1->4)-beta-D-glucose in which the hydroxy group at position 3 of the galactosyl moiety has been oxidised to the corresponding ketone.


A glycosylmannose consisting of alpha-D-galactopyranose and beta-D-mannopyranose joined in sequence by a (1->6) glycosidic bond.


A beta-D-Galf-(1->6)-D-Galf which has beta configuration at the anomeric centre.


A glycosyl glycoside consisting of alpha-D-glucopyranose and alpha-D-xylopyranose residues joined by a (1<->1) glycosidic bond.


A disaccharide comprising a D-glycero-alpha-D-talo-oct-2-ulosonyl unit in (2->4) linkage with 3-deoxy-alpha-D-manno-oct-2-ulopyranonosonic acid; it forms part of the core structure of bacterial lipopolysaccharides.


glycosylgalactose

A disaccharide which has a galactose residue at the reducing end.


A glycosylgalactose comprising two galactose units joined via an beta-(1->4) linkage.


turanose

A glycosylfructose isolated from Daphnia magna.


A D-glucosyl-D-mannose with the two components joined by an alpha-(1->2)-linkage


A glycosylgalactose consisting of D-galactose having a beta-D-galactosyl residue attached at the 6-position.


A glycosylgalactose comprising two beta-D-galactose units joined via a (1->3)-linkage.


beta-D-Manp-(1->2)-D-Manp having beta-configuration at the reducing end anomeric centre.


A disaccharide consisting of D-glucono-1,5-lactone having a beta-D-glucosyl residue at the 4-position.


A glycosylmannose consisting of a beta-D-mannopyranose residue and an alpha-D-mannopyranose residue joined in sequence by a (1->3) glycosidic bond.


A disaccharide that is D-galactopyranose in which the hydroxy group at position 4 has been converted into the corresponding beta-L-fucopyranoside.


alpha-D-Manp-(1->6)-D-Manp in which the anomeric configuration at the reducing end is beta.


A glycosylmannose consisting of beta-D-mannopyranose having a tyvelopyranosyl residue attached via an alpha-(1->3)-linkage


A glycosylgalactose in which one D-galactofuranosyl residue is linked beta(1->6) to a second D-galactofuranose residue.


keto-disaccharide

Any disaccharide that contains a keto group within its structure.


A glycosyl glycoside which is an intermediate in the breakdown of sucrose. The structure is that of sucrose in which the glucosyl 3-hydroxy group has been reduced to a keto group.


A beta-D-Galf-(1->3)-D-Galf in which the carbon bearing the anomeric hydroxy group has beta configuration.


A beta-D-Glcp-(1->4)-D-Galp in which the carbon bearing the anomeric hydroxy group has beta configuration.


A glycosylmannose consisting of an alpha-D-galactopyranose residue and a beta-D-mannopyranose residue joined in sequence by a (1->2) glycosidic bond.


A alpha-D-Gal-(1->4)-D-Gal in which both galactose residues have alpha- configuration at the anomeric centre.


A glycosylgalactose comprised of two beta-D-galactose residues linked (1->2).


A glycosylarabinose consisting of D-arabinose having a beta-D-galactosyl residue at the 3-position.


A glycosylmannose consisting of alpha-D-mannopyranose having an alpha-abequopyranosyl residue attached at the 3-position.


A glycosylmannose consisting of an alpha-D-galactopyranose residue and an alpha-D-mannopyranose residue joined in sequence by a (1->2) glycosidic bond.


An alpha-linked D-glucopyranosyl-(1->3)-D-mannopyranose compound with undefined stereochemistry at the reducing end.


A disaccharide consisting of two beta-L-arabinofuranose units joined by a (1->2)-linkage.


A glycosylgalactose consisting of an alpha-D-glucopyranose residue and a D-galactopyranose residue joined in sequence by a (1->2) glycosidic bond.


The beta-anomer of alpha-D-glucosyl-(1->3)-D-mannopyranose


glycosyl glycoside

Any disaccharide in which the two monosaccharide components are connected by a glycosidic linkage between their anomeric centres.


A disaccharide consisting of two 3-deoxy-alpha-D-manno-oct-2-ulopyranonosyl units joined via an alpha-(2->4)-linkage.


A glycosylgalactose consisting of alpha-L-fucopyranose and alpha-D-galactopyranose residues joined in sequence by a (1->2) glycosidic bond.


A glycosylgalactose consisting of an alpha-L-fucopyranose residue and a D-galactopyranose residue joined in sequence by a (1->4) glycosidic bond.


A glycosylmannose consisting of two D-mannopyranose residues joined via a beta(1->2)-linkage.


A glycosylmannose consisting of D-galactofuranose linked beta(1->2) to D-mannopyranose.


A disaccharide that is D-arabinofuranose in which the hydroxy group at position 2 has been converted into the corresponding D-mannopyranosyl derivative.


D-glucosyl-D-mannose

A glycosylmannose with both components having D-configuration.


A glycosylgalactose consisting of beta-L-fucopyranose and D-galactopyranose residues joined in sequence by a (1->2) glycosidic bond.


A glycosylgalactose consisting of beta-D-galactofuranose and D-galactofuranose residues joined in sequence by a (1->3) glycosidic bond


A glycosylmannose consisting of beta-D-galactopyranose and alpha-D-mannopyranose residues joined in sequence by a (1->6)-glycosidic bond.


A beta-D-Galp-(1->6)-D-Galf in which the carbon bearing the anomeric hydroxy group has beta configuration.


trehalose

A disaccharide formed by a (1<->1)-glycosidic bond between two units of D-glucose.


beta,beta-trehalose

A trehalose in which both glucose residues have beta-configuration at the anomeric carbon.


An alpha-D-Glcp-(1->4)-D-Galp in which the carbon bearing the anomeric hydroxy group has beta configuration.


A beta-L-Fucp-(1->3)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


A glycosylgalactose consisting of alpha-D-galactose having an alpha-L-rhamnosyl attached at the 3-position.


A glycosylgalactose consisting of beta-D-galactose having an alpha-D-glucosyl residue attached at the 2-position.


A (1->3)-linked D-glucosyl-D-mannose compound with undefined stereochemistry at both anomeric centres.


A glycosylmannose consisting of D-mannose having a beta-D-xylosyl residue attached at the 2-position.


A glycosylgalactose consisting of D-galactose having an alpha-D-galactosyl residue attached at the 6-position.


A glycosylgalactose that is alpha-D-galactopyranose in which the hydroxy group at position 3 has been converted into the corresponding beta-D-galactopyranoside.


leucrose

A glycosylfructose consisting of an alpha-D-glucopyranosyl residue joined to D-fructopyranose via a (1->5)-linkage. An isomer of sucrose.


galactobiose

Any disaccharide composed of 2 galactose moieties.


A partially-defined glycan that is alpha-D-galactopyranose in which the hydroxy group at position 2 has been glycosylated to give the corresponding D-glucopyranoside.


A glycosylrhamnose consisting of two L-rhamnopyranose units joined by an alpha(1->2) linkage.


A disaccharide comprising 3-deoxy-alpha-D-manno-oct-2-ulopyranose (Kdo) having a 3-deoxy-alpha-D-manno-oct-2-ulopyranosyl (Kdo-CH2OH) residue attached at the 4-position.


A glycosyl glycoside consisting of beta-D-galactopyranose and D-galactopyranose residues joined by a (1->1) glycosidic bond.


A glycosylmannose consisting of an alpha-D-galactopyranosyl residue attached to a D-mannopyranose at the 3-position.


A glycosylgalactose consisting of a beta-D-galactofuranose residue and a D-galactofuranose residue joined in sequence by a (1->5) glycosidic bond.


An alpha-D-Manp-(1->4)-D-Manp in which the carbon bearing the anomeric hydroxy group has beta configuration.


A disaccharide that is alpha-D-galactopyranose in which the hydroxy group at position 6 has been converted into the corresponding alpha-L-fucoside.


A glycosylgalactose consisting of D-galactose having an alpha-L-fucosyl residue attached at the 2-position.


A beta-D-Glcp-(1->4)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


A disaccharide consisting of alpha-L-rhamnose and alpha-D-galactose linked via a 1->2 glycosidic bond.


A disaccharide consisting of beta-D-galactopyranose having a D-galactopyranosyl residue attached at the 6-position via an alpha-linkage. alpha-D-Gal-(1->6)-D-Gal in which the configuration at the reducing end anomeric centre is beta.


A D-glucosyl-D-mannose with the two components joined by an beta-(1->2)-linkage and alpha-cofiguration at the reducing end anomeric centre.


A glycosylarabinose consisting of beta-D-glucopyranose and D-arabinopyranose joined in sequence by a (1->3) glycosidic bond.


A glycosylmannose consisting of alpha-D-mannose having a beta-D-mannosyl residue attached at the 2-position.


A beta-D-galactopyranosyl-(1->4)-D-galactopyranose in which the carbon bearing the anomeric hydroxy group has alpha- configuration.


A galactobiose consisting of a beta-D-galactofuranose residue and a beta-D-galactopyranose residue joined in sequence by a (1->3) glycosidic bond.


beta-epilactose

A disaccharide that is D-mannopyranose in which the hydroxy group at position 4 has been converted into the corresponding beta-D-galactopyranosyl derivative.


trehalulose

A glycosyl glycoside prepared from alpha-D-glucopyranosyl and beta-D-fructofuranose residues.


A glycosylgalactose consisting of alpha-D-galactofuranose and D-galactopyranose joined in sequence by a (1->2) glycosidic bond.


A glycosylgalactose consisting of beta-D-galactose substituted on O-6 with a beta-D-glucopyranuronosyl (beta-D-glucopyranosyluronic acid) group.


A galactobiose consisting of an alpha-D-galactofuranose residue and a beta-D-galactopyrannose residue joined in sequence by a (1->2) glycosidic bond.


A beta-D-Galp-(1->3)-L-Araf in which the carbon bearing the anomeric hydroxy group has alpha configuration.


sambubiose

A disaccharide consisting of beta-D-xylose and beta-D-glucose linked via a 1->2 glycosidic bond.


A beta-L-Fucp-(1->2)-D-Galp in which the carbon bearing the anomeric hydroxy group has beta configuration.


A disaccharide that is alpha-L-galactopyranose in which the hydroxy group at position 2 has been converted into the corresponding alpha-L-fucopyranoside


A glycosylmannose consisting of two alpha-D-mannopyranose residues linked by a (1->4) glycosidic bond.


Lys-Asp zwitterion

A dipeptide zwitterion resulting from transfer of protons from the carboxy groups to the amino groups of Lys-Asp; major species at pH 7.3.


sodium nitrilotriacetate

An organic sodium salt composed of sodium and nitrilotriacetate ions in a 3:1 ratio.


A heterocalix[4]aromatic compound composed of alternating 1,3-phenylene and 1,3,5-triazin-2,6-yl groups connected by ether linkages.


An O-(S-3-oxoacylpantetheine-4'-phosphoryl)-L-serine(1-) residue in which the S-acyl group is specified as (15Z,31Z)-3-oxopentacontadienoyl.


An amino trisaccharide consisting of alpha-L-fucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose and 2-acetamido-2-deoxy-alpha-D-galactopyranose residues joined in sequence by (1->3) and (1->6) glycosidic bonds.


Zwitterionic form of 5-guanidino-2-oxopentanoic acid.


A galactosylceramide sulfate in which the sulfo group is located at position 3 and the ceramide N-acyl group is specified as (R)-2-hydroxybehenoyl.


The stereoconfiguration is based on CHEBI:134612, pmid:20810662


A N-acylheptadecasphingosine in which the ceramide N-acyl group is specified as octadecanoyl.


D-sorbopyranose

The D-stereoisomer of sorbopyranose.


alpha-D-sorbopyranose

A D-sorbopyranose with an alpha-configuration at the anomeric center.


beta-D-sorbopyranose

A D-sorbopyranose with a beta-configuration at the anomeric center.


A chemical compound that affects cell wall integrity, sharing the common basic molecular structure of 4-chloro-6-arylamino-7-nitro-benzofurazane with 4 other CANBEF chemicals.


name: an L-amino acyl-L-threonyl dipeptide residue


A branched tetrasaccharide consisting of beta-D-glucosyl, beta-D-mannosyl and beta-D-glucosyl residues linked sequentially (1->4), to the mannosyl residue of which has also linked (1->3) to it an alpha-D-glucuronosyl residue.


GlyTouCan G03785NN

A composition-only glycan consisting of five hexosyl groups, four 2-acetaminohexosyl groups, three 6-deoxyhexosyl group and one N-acetyl-neuraminic acid group (identities and connectivity unknown). Composition: Hex5 HexNAc4 dHex3 NeuAc1.


An amino trisaccharide consisting of an alpha-D-mannopyranosyl residue and two 2-acetamido-alpha-D-glucopyranosyl residues joined in sequence by (1->4) glycosidic bonds.


lysoganglioside

Any ganglioside lacking the ceramide N-acyl group.


A lysoganglioside beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc as the sialoglycosyl component; GM1 lacking the side acyl chain.


balsaminolate

An organic sodium salt which is the monosodium salt of 2-hydroxy-3-(2-hydroxyethyl)naphthalene-1,4-dione. It is isolated from the aerial parts of Impatiens balsamina and acts as a selective inhibitor of cyclooxygenase 2 (COX-2) enzyme.


Major species at pH 7.3


Major microspecies at pH 7.3.


The organic sodium salt of 3-aminopropyl 2-acetamido-2-deoxy-alpha-D-glucose-1-phosphate


An N-(omega-linoleoyloxy-ultra-long chain fatty acyl)sphingosine where the ULCFA is 38C long and has 1 double bond at an undefined position.


N-carbamoyl-L-methionine

An N-carbamoyl-L-alpha-amino acid derived from L-methionine.


N-carbamoyl-D-methionine

An N-carbamoyl-D-alpha-amino acid derived from D-methionine.


N-carbamoyl-D-alpha-amino acid

Any N-carbamoyl-amino acid having D-configuration.


N-carbamoyl-L-amino acid

A N-carbamoyl-amino acid in which the amino acid has a L-configuration.


N-carbamoyl-L-phenylalaninate

An L-phenylalanine in which one of the hydrogens of the amino group has been replaced by a carbamoyl group; major microspecies at pH 7.3.


name: 3,3,3-trifluoro-2-[[(4-hydroxyanilino)-oxomethyl]amino]-2-phenylpropanoic acid ethyl ester


A ceramide phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of any N-acylsphing-4-enine-1-phosphoethanolamine.


An N-acylsphingosine-1-phosphoethanolamine zwitterion in which the N-acyl group is specified as hexanoyl.


benzyl beta-primeveroside

A 6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranoside in which the anomeric substituent is specified as benzyl.


A disaccharide derivative consisting of any beta-D-glucopyranoside that has an beta-D-xylopyranosyl residue attached at position 6.


2-phenylethyl beta-primeveroside

A 6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranoside in which the anomeric substituent is specified as 2-phenylethyl.


linalool 3,7-oxide beta-primeveroside

6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranoside derived from linalool 3,7-oxide.


CoA ester of ascr#23


An amino tetrasaccharide comprised of a linear sequence of N-acetyl-beta-D-galactosamine, alpha-D-galactose, beta-D-galactose and beta-D-glucose residues linked (1->3), (1->6) and (1->4).


EDTA monomagnesium salt

A magnesium salt that is the monomagnesium salt of ethylenediaminetetraacetic acid (EDTA).


magnesium orange G

A magnesium salt of a bis-sulfonated phenylazonaphthalene.


MAGNESIUM CARBONATE

A magnesium salt with formula CMgO3. Its hydrated forms, particularly the di-, tri-, and tetrahydrates occur as minerals.


magnesium acetate

The magnesium salt of acetic acid.


esomeprazole magnesium

A magnesium salt resulting from the formal reaction of magnesium hydroxide with 2 mol eq. of esomeprazole. An inhibitor of gastric acid secretion, it is used for the treatment of gastro-oesophageal reflux disease, dyspepsia, peptic ulcer disease, and Zollinger-Ellison syndrome.


magnesium citrate

A magnesium salt composed of magnesium and dibasic citrate ions in a 1:1 ratio.


MgADP

A magnesium salt composed of Mg(2+) and ADP(2-) ions in a 1:1 ratio. Magnesium-ADP is a potassium channel activator.


magnesium sulfate

A magnesium salt having sulfate as the counterion.


magnesium nitrate

The inorganic nitrate salt of magnesium.


A fluorotelomer alcohol that is ethanol substituted at position 2 by a perfluorooctyl group.


fluorotelomer alcohol

A fluoroalcohol that consists of a fluorotelomer containing an alcohol functional group. The structure of a fluorotelomer alcohol is most commonly F(CF2)nCH2CH2OH, where n is an even number.


A primary nitroalkane that is heptane substituted by a nitro group at position 1.


A 7-methyl guanosine (m7G) linked via an inverted 5'-5' triphosphate bridge to an initiating 2'-O-methyl-purine-ribonucleotide-2'-O-methyl-ribonucleotide; major species at pH 7.3


enteroendocrine cell

category: biolink:Cell biolink:AnatomicalEntity biolink:PhysicalEssence biolink:OrganismalEntity biolink:SubjectOfInvestigation biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: An endocrine cell that is located in the epithelium of the gastrointestinal tract or in the pancreas.


type M enteroendocrine cell

description: An enteroendocrine cell of the small intestine that secretes motilin.


pancreatic endocrine cell

description: An endocrine cell that is part of the pancreas.


name: neuroendocrine cell of epithelium of crypt of Lieberkuhn

description: A(n) neuroendocrine cell that is part of a(n) epithelium of crypt of Lieberkuhn.


GIP cell

description: An enteroendocrine cell of duodenum and jejunum that produces gastric inhibitory peptide.


intestinal enteroendocrine cell

description: The various hormone- or neurotransmitter-secreting cells present throughout the mucosa of the intestinal tract.


enteroendocrine cell of small intestine

description: An enteroendocrine cell that is located in the small intestine.


univalent carbothioacyl group

A univalent carbothioacyl group is a group formed by loss of OH from the thiocarboxy group of a thiocarboxylic acid.


divalent carbothioacyl group

A divalent carbothioacyl group is a group formed by loss of OH from two thiocarboxy groups of a polythiocarboxylic acid.


An amino trisaccharide consisting of alpha-L-fucopyranose, beta-D-galactopyranose and N-acetyl-beta-D-galactopyranosamine residues joined in sequence with a (1->2)- and a (1->3)-linkage, respectively; alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-GalpNAc in which the configuration at the reducing-end anomeric centre is beta.


name: GIPC-anchor amidated L-asparagine residue(1-)

description: A GIPC-anchor amidated amino acid where R1 represents the shingoid base, R2 is an acyl group, R3 can be an acyl group or an H, R4-8 can be other sugar groups, phosphoethanolamine or H.


lysine derivative

An amino acid derivative resulting from reaction of lysine at the amino group or the carboxy group, or from the replacement of any hydrogen of lysine by a heteroatom. The definition normally excludes peptides containing lysine residues.


L-lysinamide

The amino acid amide formed from L-lysine.


benzylpenicilloyl-L-lysine

An L-lysine derivative obtained from nucleophilic cleavage of the beta-lactam ring of benzylpenicillin (penicillin G) by the epsilon-amino group of the L-lysine molecule.


An L-lysine derivative in which the alpha-amino nitrogen of the amino acid has entered into amide formation with acetic acid and the epsilon-amino nitrogen carries a 1,4-dihydroxynonan-3-yl substituent. It has been synthesised by reaction of (E)-4-hydroxynon-2-enal (HNE) with N(2)-acetyl-L-lysine, the epsilon amino group of lysine reacting with the double bond function of HNE via formation of a Michael adduct.


L-lysine derivative

A proteinogenic amino acid derivative resulting from reaction of L-lysine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-lysine by a heteroatom.


an isonitrile lipopeptide

Major species at pH 7.3


A lysine derivative in which the alpha and epsilon nitrogens are substituted respectively with benzoylglycyl and 2-hydroxy-3-(quinoxalin-2-yl)propyl groups.


A lysine derivative in which the alpha-amino nitrogen of the amino acid has entered into amide formation with hippuric acid.


L-lysyl levuloglandin E2 adduct

An L-lysine derivative that is a gamma-lactam adduct formed between L-lysine and levuloglandin E2 (LGE2).


piperacilloyl-L-lysine

An L-lysine derivative obtained from nucleophilic cleavage of the beta-lactam ring of piperacillin by the epsilon-amino group of the L-lysine molecule.


Lys-GalA

An L-lysine derivative arising from amide formation between N-2 of L-lysine and the carboxy group of alpha-D-galactopyranuronic acid.


aztreonyl-L-lysine

An L-lysine derivative obtained from nucleophilic cleavage of the beta-lactam ring of aztreonam by the epsilon-amino group of the L-lysine molecule.


amoxicilloyl-L-lysine

An L-lysine derivative obtained from nucleophilic cleavage of the beta-lactam ring of amoxicillin by the epsilon-amino group of the L-lysine molecule.


A lysine derivative in which the alpha and epsilon nitrogens are substituted respectively with benzoylglycyl and 2-hydroxy-2-(3-methylquinoxalin-2-yl)ethyl groups.


D-lysopine

The N(2)-(R)-1-carboxyethyl derivative of L-lysine.


D-lysine derivative

A proteinogenic amino acid derivative resulting from reaction of D-lysine at the amino group or the carboxy group, or from the replacement of any hydrogen of D-lysine by a heteroatom.


An L-lysine derivative that is N(alpha)-citryl-L-lysine having hydroxy and acetyl substituents attached to the side-chain amino group.


albireticulene

A diterpene.


5'-end ribonucleoside residue

A nucleoside residue derived from any ribonucleoside having the linkage point at position 3'.


2'-O-methylcytidine residue

The nucleoside residue formed from 2'-O-methylcytidine with linkages at the 3' and 5' positions.


A nucleoside residue derived from (beta-D-glucopyranosyloxymethyl)deoxyuridine.


epoxyqueuosine residue

The nucleoside residue formed from epoxyqueuosine with linkages at the 3' and 5' positions.


A nucleoside residue in which an adenosine residue has been modified by substitution at C-2 by a methylthio (methylsulfanyl) group and at the 6-amino nitrogen by a Delta(2)-isopentenyl group.


2'-O-methylguanosine residue

The nucleoside residue formed from 2'-O-methylguanosine with linkages at the 2' and 5' positions.


archaeosine residue

The nucleoside residue formed from archaeosine with linkages at the 3' and 5' positions. A 7-formamidino-7-deazaguanine incorporated into a tRNA.


5'-end 2'-deoxyribonucleoside residue

A nucleoside residue derived from any 2'-deoxyribonucleoside having the linkage point at position 3'.


A nucleoside residue in which an adenosine residue has been modified by substitution at the 6-amino nitrogen by a Delta(2)-isopentenyl group.


guanosine residue

The nucleoside residue formed from guanosine with linkages at the 3' and 5' positions.


5-aminomethyl-2-thiouridine residue

The nucleoside residue formed from 5-aminomethyl-2-thiouridine with linkages at the 3' and 5' positions.


A sialodecaosylceramide where the oligosaccharide component is made up from four galactose, one galactosamine, three glucosamine, one glucose, one fucose and one sialose residue.


penicillinate salt

Any organic salt that has a penicillin as its acidic component.


name: hexakis-L-cysteinyl L-serinyl octairon heptasulfide


Fe8S7 iron-sulfur cluster

An iron-sulfur cluster containing 8 iron atoms and 7 sulfur atoms.


An N-acyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine in which the acyl group has 18 carbons and 0 double bonds and is 2-hydroxylated.


An alpha-D-Glc-(1->3')-1,2-diacylglycerol in which the groups at the 1- and 2-positions are palmitoyl and oleoyl respectively.


The dianion formed by loss of the two protons from acetylene (ethyne).


genistin 4',6''-disulfate(2-)

The conjugate base of genistin 4',6''-disulfate.


An O-(S-3-oxoacylpantetheine-4'-phosphoryl)-L-serine(1-) residue  in which the S-acyl group is specified as (11Z)-3-oxotriacontenoyl.


azamacrocycle

A cyclic macromolecule containing one or more nitrogen atoms in place of carbon either as the divalent group NH for the group CH2 or a single trivalent nitrogen atom for the group CH.


DOTA

An azamacrocyle in which four nitrogen atoms at positions 1, 4, 7 and 10 of a twelve-membered ring are each substituted with a carboxymethyl group.


A homodetic cyclic peptide resulting from the formal condensation of the carboxy group of N(2)-(3-phenylpropanoyl)-L-ornithyl-L-prolyl-3-cyclohexyl-D-alanyl-L-tryptophyl-L-arginine with the 5-amino group of the N(2)-acylornithyl residue.


triazamacrocycle

A cyclic macromolecule containing three nitrogen atoms in place of carbon either as the divalent group NH for the group CH2 or a single trivalent nitrogen atom for the group CH.


name: 3,4-dimethylindolyl precursor of nosiheptide

description: A heterodetic cyclic peptide that is an intermediate in the biosynthesis of nosiheptide by Streptomyces actuosus


name: 3-methylindolyl precursor of nosiheptide


TETA

An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.


UCL 1684

A quinolinium ion that is the dication which results from the joining of two molecules of 4-aminoquinolinium via a 1,3-dimethylbenzene linker at positions 1 and 4, thus forming a cyclic structure. It is a potent blocker of Ca(2+)-activated K(+) channels in rats.


ANIDULAFUNGIN

A semisynthetic echinocandin anti-fungal drug. It is active against Aspergillus and Candida species and is used for the treatment of invasive candidiasis.


N-methyl-L-alanine zwitterion

Zwitterionic form of N-methyl-L-alanine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.


An amino pentasaccharide consisting of five N-formyl-alpha-D-perosamine residues linked sequentially (1->2), (1->3), (1->2) and (1->2).


nafarelin

An oligopeptide comprising of 5-oxo-L-proline, L-histidine, L-tryptophan, L-serine, L-tyrosine, 3-(2-naphthyl)-D-alanine, L-leucine, L-arginine and L-prolylglycinamide residues joined sequence by peptide linkages. It is a gonadotropin releasing hormone agonist that is used to treat central precocious puberty in children and endometriosis in women.


An organic sodium salt that is the monosodium salt of 2-O-alpha-D-mannosyl-1-O-{1-O-[(10S)-10-methyloctadecanoyl]-2-O-palmitoyl-sn-glycero-3-phosphono}-5-O-palmitoyl-6-O-(6-O-palmitoyl-alpha-D-mannosyl)-1D-myo-inositol.


A member of the class of nitrotoluenes that is 2,6-dinitrotoluene bearing an additional hydroxylamino substituent at position 4.


3'-(L-valyl)adenylyl zwitterionic group

A zwitterionic group obtained by transfer of a proton from the phosphate to the amino group of 3'-(L-prolyl)adenylyl group


A  diarylheptanoid that is hept-6-en-3-ol substituted by two 4-hydroxyphenyl groups at the terminal carbon atoms respectively (the S-stereoisomer). It has been isolated from the rhizomes of Curcuma kwangsiensis and has been shown to inhibit NO production.


L-methionine (S)-S-oxide zwitterion

Zwitterionic form of L-methionine (S)-S-oxide.


A nucleotide residue derived from 2-thio-N(6)-L-threonylcarbamoyladenine 5'-monophosphate with linkages at the 3'- and 5'-positions.


right caudal basal body

description: Any ciliary basal body that is part of a right caudal flagellum found in Giardia species (trophozoite stage).


Ala-Gly-Ala-Gly

A tetrapeptide composed of L-alanine, glycine, L-alanine, and glycine residues joined in sequence by peptide linkages.


A glycosyl alditol consisting of beta-D-galactopyranose and D-galactitol joined in sequence by a (1->6) glycosidic bond.


name: 3,5-Dimethoxy-4-[(alpha-L-rhamnopyranosyl)oxy]benzoic acid methyl ester


A branched octasaccharide consisting of two repeating tetrasaccharide units; isolated from phage P22 endo-rhamnosidase cleaved S. typhimurium O-polysaccharide chains.


A glycoside formed between the branched tetrasaccharide alpha-L-Fuc-(1->2)-[alpha-D-Gal-(1->3)]-beta-D-Gal-(1->4)-beta-D-Glc and the alkenyl alcohol oct-7-en-1-ol.


A dihydroceramide in which the acyl moiety contains 26 carbons and 1 double bond.


A dihydroceramide in which the ceramide N-acyl group is specified as (17Z)-hexacosenoyl


Ac-SDKP

A tetrapeptide that is Ser-Asp-Lys-Pro in which the N-terminal amino group carries an acetyl group. It is selective inhibitor of primitive haematopoietic cell proliferation and exhibits anti-inflammatory, anti-fibrotic, and pro-angiogenic properties.


Achimugu mEC2

Structure compound isolated from methanol extract of Eucalyptus camaldulensis


A fatty-acyl group derived from (9Z,12Z)-octadeca-9,12-dien-6-ynoic acid.


4-nitrobenzyl bromide

A C-nitro compound that consists of nitrobenzene bearing a bromomethyl substituent at the para-position.


alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc in which the anomeric configuration of the reducing-end N-acetyl-D-glucosamine residue is beta.


An O-(S-acylpantetheine-4'-phosphoryl)serine(1-) residue in which the S-acyl group is specified as (3R)-hydroxynonanoyl.


beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-D-GalpNAc with alpha-configuration at the anomeric centre of the reducing-end GalNAc residue.


An alkene that is undec-1-ene carrying a methyl substituent at position 8.


An amino disaccharide composed of 3-sulfated beta-D-galactose and N-acetyl-beta-D-glucosaminyl residues in beta-(1->3) linkage.


MPP+

A pyridinium ion that is N-methylpyridinium having a phenyl substituent at the 4-position.


GJ1012 C

A diterpene.


AMMONIA N-13

A (13)N-modified compound that is ammonia that has a (13)N isotope as the nitrogen atom. (13)N decays with a half-life of ten minutes to (13)C, emitting a positron. Used in diagnostic Positron Emission Tomography (PET) imaging.


lucumin

A disaccharide derivative that is 6-O-beta-D-xylopyranosyl-beta-D-glucopyranose having an (R)-mandelonitrile group at the anomeric position.


cholinergic synapse

description: A synapse that uses acetylcholine as a neurotransmitter.


An alpha-amino-acid residue anion obtained by the addition of 2 AMP residues connected by a 3'->5' phosphodiester linkage on a L-tyrosine residue; major species at pH 7.3.


disodium fumarate

An organic sodium salt resulting from the replacement of the protons from the carboxy groups of fumaric acid by sodium ions.